|1.||Duc, Marie-Francoise: 2 articles (02/2004 - 11/2003)|
|2.||Guédon-Moreau, Laurence: 2 articles (02/2004 - 11/2003)|
|3.||Quieureux, Yves: 2 articles (02/2004 - 11/2003)|
|4.||L'Hôte, Catherine: 2 articles (02/2004 - 11/2003)|
|5.||Caron, Jacques: 2 articles (02/2004 - 11/2003)|
|6.||Ducrocq, Dominique: 2 articles (02/2004 - 11/2003)|
|7.||Deligne, Jean: 2 articles (02/2004 - 11/2003)|
|8.||Sacchetta, P: 1 article (04/2013)|
|9.||Archararit, N: 1 article (04/2013)|
|10.||Maenthaisong, R: 1 article (04/2013)|
07/01/1980 - "[Use of floctafenine for dental pain of adults and children; a controlled study. "
09/08/1977 - "[Floctafenine in the treatment of odonto-stomatologic pain]."
05/01/1976 - "Pain on walking and joint stiffness after sitting were significantly less on floctafenine. "
05/01/1976 - "There was a significant patient preference for, and a greater relief of pain with, floctafenine. "
05/08/1980 - "The results demonstrated that tiapride is more active than floctafenine for the treatment of rheumatic pains having a psychic component, while floctafenine is best indicated for pain of purely mechanical origin."
05/01/1976 - "Floctafenine 200 mg four times a day was compared with placebo in 30 out-patients with osteoarthrosis in a double-blind controlled study. "
05/01/1976 - "A controlled trial of the analgesic effects of Floctafenine against placebo in osteoarthrosis."
01/01/1978 - "The results indicate that in the treatment of osteoarthrosis, floctafenine is comparable to ibuprofen (in the dose used in the study) in terms of efficacy and toxicity."
05/01/1997 - "A multicenter, double-blind, cross-over, random-order study compared the efficacy of floctafenin, 800 mg/day and acetaminophen, 3000 mg/day, in providing pain relief to 192 patients with chronic pain due to osteoarthritis in the lower limbs. "
05/01/1997 - "Floctafenin versus acetaminophen for pain control in patients with osteoarthritis in the lower limbs. "
|3.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/01/1992 - "When comparing the results of these trials, it appears that in the GIMEMA group the capability of offering effective treatment to elderly patients with ANLL has continuously improved and that IDARAC plus Mitoxantrone is so far the most active and best tolerated regimen. "
04/01/1997 - "Sixty-one adult patients with relapsed or refractory acute myelogenous leukemia (AML) were treated in a cooperative study with Idarubicin 12 mg/m2/day on days 1 to 3 and AraC 1 g/m2/12h on days 1 to 4. Responding patients were scheduled for consolidation with Ida-IDAraC and bone marrow transplantation (BMT) when feasible. "
|5.||Back Pain (Backache)
|4.||Aspirin (Acetylsalicylic Acid)
|5.||Idarubicin (4 Demethoxydaunorubicin)
|1.||Bone Marrow Transplantation (Transplantation, Bone Marrow)
|2.||Oral Surgery (Maxillofacial Surgery)